{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Healthy Enterprise","title":"Vision Meets Innovation: Leading in Life Sciences with David Esposito","html":"","width":"100%","height":180,"duration":2330,"description":"In this episode, we interview David Esposito, an experienced healthcare CEO with a background in both large pharma and early-stage biotech. David discusses his career journey, insights into leading and scaling healthcare companies, and the challenges and opportunities in developing innovative therapies for diseases of the eye. He also shares his perspective on leadership, team building, and the importance of maintaining a focus on patient outcomes.Chapters/Timestamps:00:00 - Introduction and David Esposito's Background02:09 - ONL Therapeutics and its Focus09:05 - David Esposito’s Career Journey24:47 - Leadership and Team Building32:35 - Challenges in Biotech and Company Growth48:22 - Marketing and Clinical Trial Enrollment58:52 - Funding and Future Outlook1:09:09 - Inspiration and Advice1:19:31 - The Future of Healthcare InnovationGuest Information:Guest's Name: David EspositoGuest's Title/Position: CEOCompany/Affiliation: ONL TherapeuticsGuest's Bio: David Esposito is an experienced healthcare CEO with over thirty years in the industry. He has a background in large pharma and has built and scaled multiple early to mid-stage life science companies. Currently, he is the CEO of ONL Therapeutics, a mid-stage biotech company focused on developing therapies for diseases of the eye.Links and Resources:ONL Therapeutics: https://onltherapeutics.com/RA Capital: https://www.racap.com/Andreessen Horowitz: https://a16z.com/","thumbnail_url":"https://img.transistorcdn.com/WKku9MQ84q-0q9Awqd5xdS4eoTolo1ocic6_1x8xlF0/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mMjI4/MDliNWYyM2MxYWFi/NTkwZmIwNzJkYjk2/YjliMy5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}